# Measurement of Treatment Effects

> **NCT07024303** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Matthew J O'Brien, PhD, BCBA-D** · enrollment: 20 (estimated)

## Conditions studied

- Challenging Behavior
- Autism Spectrum Disorder

## Interventions

- **DRUG:** Psychotropic medication (at discretion of psychiatrist)
- **BEHAVIORAL:** Behavioral therapy

## Key facts

- **NCT ID:** NCT07024303
- **Lead sponsor:** Matthew J O'Brien, PhD, BCBA-D
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2027-07-01
- **Final completion:** 2027-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07024303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07024303, "Measurement of Treatment Effects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07024303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*